Immune response induced by a linear DNA vector: Influence of dose, formulation and route of injection

Vaccine

Volumn 28, Issue 21, 2010, Pages 3642-3649

  Endmann, Anne ^a   Baden, Michael ^b   Weisermann, Elena ^b   Kapp, Kerstin ^a   Schroff, Matthias ^a   Kleuss, Christiane ^a   Wittig, Burghardt ^c   Juhls, Christiane ^a  

^a MOLOGEN AG   (Germany)

^b LPT Laboratory of Pharmacology and Toxicology   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

DNA vaccine; MIDGE; Transfection reagent

Indexed keywords

AMPHOPHILE; CATION; DNA VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; PYRIDINIUM DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA VECTOR; DRUG DOSE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOGENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; TH1 CELLS; VACCINATION; VACCINES, DNA;

EID: 77953128888     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.034     Document Type: Article

References (45)

1. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 247 4949 (Pt 1) (1990) 1465-1468
2. Tang D.C., DeVit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 6365 (1992) 152-154
3. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu Rev Immunol 15 (1997) 617-648
4. Coban C., Koyama S., Takeshita F., Akira S., and Ishii K.J. Molecular and cellular mechanisms of DNA vaccines. Hum Vaccin 4 6 (2008) 453-456
5. Kutzler M.A., and Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 9 10 (2008) 776-788
6. Garmory H.S., Brown K.A., and Titball R.W. DNA vaccines: improving expression of antigens. Genet Vaccines Ther 1 1 (2003) 2
7. Stevenson F.K. DNA vaccines and adjuvants. Immunol Rev 199 (2004) 5-8
8. Fuller D.H., Loudon P., and Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40 1 (2006) 86-97
9. Luxembourg A., Evans C.F., and Hannaman D. Electroporation-based DNA immunisation: translation to the clinic. Expert Opin Biol Ther 7 11 (2007) 1647-1664
10. Greenland J.R., and Letvin N.L. Chemical adjuvants for plasmid DNA vaccines. Vaccine 25 19 (2007) 3731-3741
11. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., Robinson H.L., Santoro J.C., Fuller J.T., et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5 5 (1999) 287-300
12. Bosarge J.R., Watt J.M., McDaniel D.O., Swiatlo E., and McDaniel L.S. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Infect Immun 69 9 (2001) 5456-5463
13. Cui F.D., Asada H., Kishida T., Itokawa Y., Nakaya T., Ueda Y., et al. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice. Gene Ther 10 25 (2003) 2059-2066
14. Fu T.M., Guan L., Friedman A., Schofield T.L., Ulmer J.B., Liu M.A., et al. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J Immunol 162 7 (1999) 4163-4170
15. Kadowaki S., Chen Z., Asanuma H., Aizawa C., Kurata T., and Tamura S. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Vaccine 18 25 (2000) 2779-2788
16. Liu J., Hellerstein M., McDonnel M., Amara R.R., Wyatt L.S., Moss B., et al. Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. Vaccine 25 15 (2007) 2951-2958
17. McClements W.L., Armstrong M.E., Keys R.D., and Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA 93 21 (1996) 11414-11420
18. Mayrhofer P., Blaesen M., Schleef M., and Jechlinger W. Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography. J Gene Med 10 11 (2008) 1253-1269
19. Kendirgi F., Yun N.E., Linde N.S., Zacks M.A., Smith J.N., Smith J.K., et al. Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1. Hum Vaccin 4 6 (2008) 410-419
20. Moreno S., Lopez-Fuertes L., Vila-Coro A.J., Sack F., Smith C.A., Konig S.A., et al. DNA immunisation with minimalistic expression constructs. Vaccine 22 13-14 (2004) 1709-1716
21. Lopez-Fuertes L., Perez-Jimenez E., Vila-Coro A.J., Sack F., Moreno S., Konig S.A., et al. DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine 21 3-4 (2002) 247-257
22. Schirmbeck R., Konig-Merediz S.A., Riedl P., Kwissa M., Sack F., Schroff M., et al. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide. J Mol Med 79 5-6 (2001) 343-350
23. Zheng C., Juhls C., Oswald D., Sack F., Westfehling I., Wittig B., et al. Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D. Vaccine 24 21 (2006) 4625-4629
24. Audouy S.A., de Leij L.F., Hoekstra D., and Molema G. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm Res 19 11 (2002) 1599-1605
25. Scarzello M., Chupin V., Wagenaar A., Stuart M.C., Engberts J.B., and Hulst R. Polymorphism of pyridinium amphiphiles for gene delivery: influence of ionic strength, helper lipid content, and plasmid DNA complexation. Biophys J 88 3 (2005) 2104-2113
26. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics 20 (1964) 482-491
27. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Gluckman S.J., Bagarazzi M.L., et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 178 1 (1998) 92-100
28. Rottinghaus S.T., Poland G.A., Jacobson R.M., Barr L.J., and Roy M.J. Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 21 31 (2003) 4604-4608
29. Le T.P., Coonan K.M., Hedstrom R.C., Charoenvit Y., Sedegah M., Epstein J.E., et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18 18 (2000) 1893-1901
30. Sharpe M., Lynch D., Topham S., Major D., Wood J., and Loudon P. Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine 25 34 (2007) 6392-6398
31. Cardoso A.I., Sixt N., Vallier A., Fayolle J., Buckland R., and Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen. J Virol 72 3 (1998) 2516-2518
32. Oran A.E., and Robinson H.L. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells. J Immunol 171 4 (2003) 1999-2005
33. Harty J.T., Tvinnereim A.R., and White D.W. CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 18 (2000) 275-308
34. Wasungu L., and Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Controlled Release 116 2 (2006) 255-264
35. van Kilsdonk J.W., Wilting R.H., Bergers M., van Muijen G.N., Schalkwijk J., van Kempen L.C., et al. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule. Cancer Res 68 10 (2008) 3671-3679
36. Jilg W., Schmidt M., and Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 6 (1988) 201-207
37. Hartikka J., Bozoukova V., Ferrari M., Sukhu L., Enas J., Sawdey M., et al. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine 19 15-16 (2001) 1911-1923
38. McIlroy D., Barteau B., Cany J., Richard P., Gourden C., Conchon S., et al. DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination. Mol Ther 17 8 (2009) 1473-1481
39. Bohm W., Mertens T., Schirmbeck R., and Reimann J. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 16 9-10 (1998) 949-954
40. Danko I., Williams P., Herweijer H., Zhang G., Latendresse J.S., Bock I., et al. High expression of naked plasmid DNA in muscles of young rodents. Hum Mol Genet 6 9 (1997) 1435-1443
41. Paul L., and Porgador A. DNA-based vaccines: role of dendritic cells in antigen presentation. Adv Exp Med Biol 479 (2000) 175-184
42. Chattergoon M.A., Robinson T.M., Boyer J.D., and Weiner D.B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 160 12 (1998) 5707-5718
43. Fu T.M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 3 6 (1997) 362-371
44. Tuting T., Storkus W.J., and Falo Jr. L.D. DNA immunization targeting the skin: molecular control of adaptive immunity. J Invest Dermatol 111 2 (1998) 183-188
45. Dupuis M., Denis-Mize K., Woo C., Goldbeck C., Selby M.J., Chen M., et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 165 5 (2000) 2850-2858